← Browse by Condition
Medical Condition
sarcoma soft tissue
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06074692 Phase 2
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Enrollment
86 pts
Location
China
Sponsor
Ruijin Hospital
NCT04673942 Phase 2
Recruiting
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
Enrollment
140 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT06408441
Recruiting
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Enrollment
100 pts
Location
Austria, Denmark, Fr...
Sponsor
Fondazione IRCCS Istituto Nazi...